SO
DNA X, Inc.
SONM · NASDAQ
$3.02 +4.14% (+$0.12)
1M -8.08%
Market Cap $4.49M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$4.28
41.7% upside
Current Price
$3.02
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SONM is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
0/9Valuation
100 /100
Cheap P/S -0.16x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
77 /100
Strong Gross margin 48.37%
Net margin 30.62%
Op. margin 15.10%
Quality
0 /100
Poor ROIC 434.68%
ROA 189.22%
Asset turnover -6.18x
Debt
1 /100
High Current ratio 0.57x
Int. coverage -4.01x
Debt/Equity N/A
Stability
7 /100
Unstable Beta 1.86x
Rev. volatility 67.10%
EPS volatility 19,595.86%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SONM
Online
Sector
Technology
Industry
Communication Equipment
CEO
Michael C. Mulica
Employees
4
Headquarters
San Diego
Upcoming events
17 NOV
Earnings
Upcoming earnings report